Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines

K. R. Valetdinova, Marianna Maretina, Mirya Kuranova, Yu. M. Minina, Elena A. Kizilova, Anton Kiselev, S. P. Medvedev, Suren M. Zakian

Stem Cell Research · 2019 · 12 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

Spinal muscular atrophy (SMA) is a neuromuscular disease caused by deletion or mutation in SMN1 gene. SMA human induced pluripotent stem cells (iPSCs) represent a useful and valid model for the study of the disorder, as they provide in vitro the target cells. We generated iPSCs from a SMA type I patient and SMA type II patient by using non-integrating episomal plasmid vectors. The resulting iPSCs are episomal-free, express pluripotency markers, display a normal karyotype, retain the mutation (homozygous deletion of SMN1) and are able to differentiate into the three germ layers.

References

5